Literature DB >> 28696213

Ca2+ Regulation of Cav3.3 T-type Ca2+ Channel Is Mediated by Calmodulin.

Narae Lee1, Sua Jeong1, Kang-Chang Kim1, Jin-Ah Kim1, Jin-Yong Park1, Ho-Won Kang1, Edward Perez-Reyes1, Jung-Ha Lee2.   

Abstract

Calcium-dependent inactivation of high voltage-activated Ca2+ channels plays a crucial role in limiting rises in intracellular calcium (Ca2+i). A key mediator of these effects is calmodulin, which has been found to bind the C-terminus of the pore-forming α subunit. In contrast, little is known about how Ca2+i can regulate low voltage-activated T-type Ca2+ channels. Using whole cell patch clamp, we examined the biophysical properties of Ca2+ current through the three T-type Ca2+ channel isoforms, Cav3.1, Cav3.2, or Cav3.3, comparing internal solutions containing 27 nM and l μM free Ca2+ Both activation and inactivation kinetics of Cav3.3 current in l μM Ca2+i solution were more rapid than those in 27 nM Ca2+i solution. In addition, both activation and steady-state inactivation curves of Cav3.3 were negatively shifted in the higher Ca2+i solution. In contrast, the biophysical properties of Cav3.1 and Cav3.2 isoforms were not significantly different between the two internal solutions. Overexpression of CaM1234 (a calmodulin mutant that doesn't bind Ca2+) occluded the effects of l μM Ca2+i on Cav3.3, implying that CaM is involved in the Ca2+i regulation effects on Cav3.3. Yeast two-hybrid screening and co-immunoprecipitation experiments revealed a direct interaction of CaM with the carboxyl terminus of Cav3.3. Taken together, our results suggest that Cav3.3 T-type channel is potently regulated by Ca2+i via interaction of Ca2+/CaM with the carboxyl terminus of Cav3.3.
Copyright © 2017 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28696213     DOI: 10.1124/mol.117.108530

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.054


  4 in total

Review 1.  Evolving mechanisms of vascular smooth muscle contraction highlight key targets in vascular disease.

Authors:  Zhongwei Liu; Raouf A Khalil
Journal:  Biochem Pharmacol       Date:  2018-02-13       Impact factor: 5.858

Review 2.  Neuronal Cav3 channelopathies: recent progress and perspectives.

Authors:  Philippe Lory; Sophie Nicole; Arnaud Monteil
Journal:  Pflugers Arch       Date:  2020-07-07       Impact factor: 3.657

3.  Mitochondrial dysfunction reduces the activity of KIR2.1 K+ channel in myoblasts via impaired oxidative phosphorylation.

Authors:  JooHan Woo; Hyun Jong Kim; Yu Ran Nam; Yung Kyu Kim; Eun Ju Lee; Inho Choi; Sung Joon Kim; Wan Lee; Joo Hyun Nam
Journal:  Korean J Physiol Pharmacol       Date:  2018-10-25       Impact factor: 2.016

4.  Calmodulin regulates Cav3 T-type channels at their gating brake.

Authors:  Jean Chemin; Valentina Taiakina; Arnaud Monteil; Michael Piazza; Wendy Guan; Robert F Stephens; Ashraf Kitmitto; Zhiping P Pang; Annette C Dolphin; Edward Perez-Reyes; Thorsten Dieckmann; Joseph Guy Guillemette; J David Spafford
Journal:  J Biol Chem       Date:  2017-09-25       Impact factor: 5.157

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.